What is the dosing regimen for Pylera (bismuth subcitrate, metronidazole, tetracycline)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pylera Dosing Regimen

The standard dose of Pylera is 3 capsules taken four times daily (after meals and at bedtime) for 10 days, combined with a proton pump inhibitor (PPI) twice daily. 1

Specific Dosing Details

Pylera Components (per 3-capsule dose):

  • Bismuth subcitrate potassium: 420 mg (140 mg × 3 capsules)
  • Metronidazole: 375 mg (125 mg × 3 capsules)
  • Tetracycline hydrochloride: 375 mg (125 mg × 3 capsules)

Complete Regimen:

  • Pylera: 3 capsules four times daily (after breakfast, lunch, dinner, and at bedtime)
  • PPI: Omeprazole 20 mg twice daily (after morning and evening meals) 1
  • Duration: 10 days 1

Administration Instructions:

  • Take with a full glass of water (8 ounces) 1
  • Swallow capsules whole 1
  • Take after meals and at bedtime to reduce gastrointestinal side effects
  • Adequate fluid intake with the bedtime dose is particularly important to reduce esophageal irritation risk from tetracycline 1

Alternative PPI Options

While the FDA label specifies omeprazole 20 mg twice daily, current guidelines recommend higher-potency PPIs for optimal outcomes 2. Consider:

  • Esomeprazole 20-40 mg twice daily (preferred)
  • Rabeprazole 20-40 mg twice daily (preferred)
  • Lansoprazole 30-45 mg twice daily
  • Avoid pantoprazole due to lower relative potency 2

Duration Considerations

While Pylera is FDA-approved and packaged for 10 days, current international guidelines recommend 14 days for bismuth quadruple therapy to maximize eradication rates 3. The Toronto, Maastricht V/Florence, and ACG consensus guidelines all support 14-day duration for first-line therapy 3. However, 10 days may be acceptable if proven locally effective 3.

Practical Approach:

  • First-line therapy: Consider 14 days if prescribing components separately (bismuth, tetracycline, metronidazole individually) 3
  • Using Pylera package: 10 days is acceptable given the product packaging and FDA approval 1
  • Rescue therapy: 14 days preferred 3

Twice-Daily Alternative (Off-Label)

Research supports a twice-daily regimen as an alternative with similar efficacy and potentially better tolerability 4, 5, 6:

  • Pylera 2 capsules + tetracycline 250 mg + metronidazole 250 mg twice daily (total 500 mg each antibiotic per dose)
  • PPI twice daily
  • Duration: 10-14 days

This achieves 93-96% eradication rates with fewer gastrointestinal side effects 4, 5, 6, though this is not FDA-approved dosing.

Important Caveats

Contraindications:

  • Pregnancy (tetracycline causes permanent tooth discoloration in second/third trimester) 1
  • Children under 8 years (tooth enamel effects) 1
  • Severe renal impairment 1
  • Recent disulfiram use (within 2 weeks) 1

Critical Drug Interactions:

  • Avoid alcohol during therapy and for 3 days after (disulfiram-like reaction) 1
  • Separate from antacids, multivitamins, dairy products by several hours (decreased absorption) 1
  • Monitor anticoagulation closely if on warfarin 1

Missed Doses:

If a dose is missed, continue the normal schedule—do not double dose. If more than 4 doses are missed, contact the prescriber 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.